BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32564058)

  • 1. Pregnancy Outcomes of Women Conceiving on Antiretroviral Therapy (ART) Compared to Those Commenced on ART During Pregnancy.
    Theron G; Brummel S; Fairlie L; Pinilla M; McCarthy K; Owor M; Chinula L; Makanani B; Violari A; Moodley D; Chakhtoura N; Browning R; Hoffman R; Fowler MG
    Clin Infect Dis; 2021 Jul; 73(2):e312-e320. PubMed ID: 32564058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrollment and transition challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) network's PROMISE trial for resource-limited regions.
    Angelidou K; Fowler MG; Flynn P; Coletti A; McCarthy K; Browning R; McIntyre J; Brummel SS; Shapiro DE; Tierney C;
    Clin Trials; 2020 Aug; 17(4):437-447. PubMed ID: 32191142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding.
    Brummel SS; Taha TE; Angelidou KN; Saidi F; Atuhaire P; Dula D; Moodley D; Matubu A; Chareka G; Nevrekar N; Vhembo T; Fairlie L; Theron G; Mlay P; George K; Basar M; Chakhtoura N; Browning R; Fowler MG; Currier JS;
    J Acquir Immune Defic Syndr; 2021 Apr; 86(4):450-454. PubMed ID: 33273210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
    Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
    PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy.
    Hoffman RM; Brummel SS; Britto P; Pilotto JH; Masheto G; Aurpibul L; Joao E; Purswani MU; Buschur S; Pierre MF; Coletti A; Chakhtoura N; Klingman KL; Currier JS;
    Clin Infect Dis; 2019 Jan; 68(2):273-279. PubMed ID: 29868833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis.
    Uthman OA; Nachega JB; Anderson J; Kanters S; Mills EJ; Renaud F; Essajee S; Doherty MC; Mofenson LM
    Lancet HIV; 2017 Jan; 4(1):e21-e30. PubMed ID: 27864000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe.
    Dinh TH; Mushavi A; Shiraishi RW; Tippett Barr B; Balachandra S; Shambira G; Nyakura J; Zinyowera S; Tshimanga M; Mugurungi O; Kilmarx PH
    Clin Infect Dis; 2018 Feb; 66(4):576-585. PubMed ID: 29401270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal Humoral Immune Responses Do Not Predict Postnatal HIV-1 Transmission Risk in Antiretroviral-Treated Mothers from the IMPAACT PROMISE Study.
    Hompe ED; Jacobson DL; Eudailey JA; Butler K; Edwards W; Pollara J; Brummel SS; Fouda GG; Chinula L; Kamanga M; Kinikar A; Moodley D; Owor M; Fowler MG; Permar SR
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31645430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes.
    Marazzi MC; Palombi L; Nielsen-Saines K; Haswell J; Zimba I; Magid NA; Buonomo E; Scarcella P; Ceffa S; Paturzo G; Narciso P; Liotta G
    AIDS; 2011 Aug; 25(13):1611-8. PubMed ID: 21673553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy.
    Stringer EM; Kendall MA; Lockman S; Campbell TB; Nielsen-Saines K; Sawe F; Cu-Uvin S; Wu X; Currier JS
    PLoS One; 2018; 13(7):e0199555. PubMed ID: 30020964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: Systematic review and network meta-analysis including different study designs.
    Veroniki AA; Antony J; Straus SE; Ashoor HM; Finkelstein Y; Khan PA; Ghassemi M; Blondal E; Ivory JD; Hutton B; Gough K; Hemmelgarn BR; Lillie E; Vafaei A; Tricco AC
    PLoS One; 2018; 13(6):e0198447. PubMed ID: 29912896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
    Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial.
    Kesho Bora Study Group
    Clin Infect Dis; 2012 Aug; 55(3):449-60. PubMed ID: 22573845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for HIV Infection in Pregnant Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Selph SS; Bougatsos C; Dana T; Grusing S; Chou R
    JAMA; 2019 Jun; 321(23):2349-2360. PubMed ID: 31184704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infant Human Immunodeficiency Virus-free Survival in the Era of Universal Antiretroviral Therapy for Pregnant and Breastfeeding Women: A Community-based Cohort Study From Rural Zambia.
    Chi BH; Mutale W; Winston J; Phiri W; Price JT; Mwiche A; Ayles H; Stringer JSA
    Pediatr Infect Dis J; 2018 Nov; 37(11):1137-1141. PubMed ID: 29601456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2016; 28 Suppl 1(sup1):114-8. PubMed ID: 26922939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.